Live FDA News

Live FDA news coverage of developments with the latest updates. Stay on top of latest FDA news stories and find out what just happened, what is going on with FDA. The latest real-time news updates and headlines on FDA
MD Anderson research highlights for December 6, 2021
Protein variant identified that renders chemotherapy ineffective in gastric cancer
FDA panel advances Covid antiviral discovered at Emory
Hearing Loss is Inevitable – When’s Right Time for Hearing Aid?
Additional Covid vaccine recommended for all adults, especially in light of Omicron variant
New vaccine ingredient reveals promise
Immune system-stimulating nanoparticle could lead to more powerful vaccines
U.S. President Biden’s Remarks on COVID- 19 Winter Plan
Research on human embryo models paves way for improving in vitro fertilization success rate and new non-hormonal
Background Press Call by Senior Administration Officials on New Actions to Protect Americans Against Delta and Omicron Variants This
President Biden Announces New Actions to Protect Americans Against Delta and Omicron Variants as We Battle COVID- 19 this Winter
US FDA grants new fast designation for Bionomics’ BNC210
Sickle Cell Clinical Trial Aims to Cure Disease by Correcting Patient’s Mutated Gene
Potential new treatment for Alzheimer’s disease would be relatively cheap
Press Briefing by White House COVID- 19 Response Team and Public Health Officials 1 December
FDA Approves “Glowing Tumor” Imaging Drug to Better Identify Ovarian Cancer Cells Using Approach Pioneered by Surgeons
Diagnosing breast cancer
Lynparza granted Priority Review in US for BRCA-mutated HER2-negative high-risk early breast cancer
Research on over million people reveals breakthrough Covid infections occur more often and are more severe
Press Briefing by Press Secretary Jen Psaki, November 29, 2021
Remarks by President Biden Providing an Update on Omicron Variant
FDA approves pioneering drug for ovarian cancer surgery
UT Southwestern launches SPORE-funded national resource to advance precision medicine for kidney cancer
Innovative silicone nanochip can reprogram biological tissue in living body
Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY in Children 5 to
Hepatitis Drug Increases Antibiotic Potency, Limits Antibiotic Resistance
Hepatitis drug increases antibiotic potency, limits drug resistance
Press Briefing by White House COVID- 19 Response Team and Public Health Officials 23 November
Wearable injector can detect and reverse opioid overdose
Preparing anti-Covid agent EIDD-2801 by practical and scalable approach, and quick evaluation via machine learning
Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech Covid Vaccine Support Safety and High Efficacy
Wearable device can detect and reverse opioid overdose
CDC Expands Eligibility for Covid Booster Shots to All Adults
Pfizer and BioNTech Receive Expanded U.S. FDA Emergency Use Authorization of Covid Vaccine Booster to Include Individuals 18
FDA’s Lax Oversight of Research in Developing Countries Can Do Harm to Vulnerable Participants
Remarks by President Biden, Prime Minister Trudeau of Canada, and President López Obrador of Mexico Before North American Leaders’
New evidence that mass treatment with Ivermectin has halted spread of river blindness in two Nigerian states
Start with Day One- You Can Quit
Statement of President Joe Biden on Pfizer’s COVID- 19 Antiviral Treatment
TIP Company ImStem Biotechnology Doses First MS Patient in Clinical Trial
Dana-Farber research supports FDA approval of immunotherapy drug given after surgery for certain patients with kidney cancer
Pfizer to Provide U.S. Government with 10 Million Treatment Courses of Investigational Oral Antiviral Candidate to Help Combat Covid
New analyses of two AZD7442 Covid Phase III trials in high-risk populations confirm robust efficacy and long-term prevention
Press Briefing by White House COVID- 19 Response Team and Public Health Officials 18 November
FDA Approves Focused Ultrasound for Common Parkinson’s Symptoms
UConn Doctors Provide Lung Cancer Screenings for Community
Newer consumer product industry CEOs more likely to issue recalls than veteran leaders
Pfizer Seeks Emergency Use Authorization for Novel Covid Oral Antiviral Candidate